1 Profitable Stock to Target This Week and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two best left off your watchlist.
Two Stocks to Sell:
DocuSign (DOCU)
Trailing 12-Month GAAP Operating Margin: 9.3%
Creating the digital equivalent of "sign on the dotted line" for over a billion users worldwide, DocuSign (NASDAQ:DOCU) provides an agreement management platform that enables businesses to electronically prepare, sign, and manage documents and contracts.
Why Does DOCU Fall Short?
- Customers were hesitant to make long-term commitments to its software as its 8.7% average ARR growth over the last year was sluggish
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 8.4%
- Operating profits increased over the last year as the company gained some leverage on its fixed costs and became more efficient
DocuSign is trading at $47.66 per share, or 2.7x forward price-to-sales. To fully understand why you should be careful with DOCU, check out our full research report (it’s free).
Bio-Techne (TECH)
Trailing 12-Month GAAP Operating Margin: 9.6%
With a catalog of hundreds of thousands of specialized biological products used in laboratories worldwide, Bio-Techne (NASDAQ:TECH) develops and manufactures specialized reagents, instruments, and services that help researchers study biological processes and enable diagnostic testing and cell therapy development.
Why Do We Pass on TECH?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Smaller revenue base of $1.22 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- 11.6 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
Bio-Techne’s stock price of $61.20 implies a valuation ratio of 28.8x forward P/E. If you’re considering TECH for your portfolio, see our FREE research report to learn more.
One Stock to Buy:
Monster (MNST)
Trailing 12-Month GAAP Operating Margin: 29.4%
Founded in 2002 as a natural soda and juice company, Monster Beverage (NASDAQ:MNST) is a pioneer of the energy drink category, and its Monster Energy brand targets a young, active demographic.
Why Is MNST a Top Pick?
- Disciplined cost controls and effective management resulted in a strong two-year operating margin of 27.7%, and its profits increased over the last year as it scaled
- Strong free cash flow margin of 23% enables it to reinvest or return capital consistently, and its improved cash conversion implies it’s becoming a less capital-intensive business
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures, and its rising returns show it’s making even more lucrative bets
At $77.82 per share, Monster trades at 34.1x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
